Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species.

作者: Emilia Cantón , Javier Pemán , Angel Viudes , Guillermo Quindós , Miguel Gobernado

DOI: 10.1016/S0732-8893(02)00525-4

关键词:

摘要: Abstract Minimum fungicidal concentrations (MFCs) of amphotericin B were obtained for 165 bloodstream isolates (104 Candida parapsilosis, 14 C.glabrata, 13 C.tropicalis, 15 C.krusei, and 19 C.albicans ) 36 C.dubliniensis from oropharyngeal infections. inhibitory (MICs) determined by the M27-A microdilution method. MFCs (≥99.9% killing) following MIC determination (inoculum size, 10 4 CFU/ml) seeding entire volume all clear wells. The best activity was C. albicans, (MFC 90 1 μg/ml) lowest C.parapsilosis, C.tropicalis C.glabrata 16 μg/ml). Although ≥16× some isolates, including glabrata, overall ≥2× MICs. However, major differences between MICs observed C.parapsilosis (3.8% 8.9%, respectively, tolerant: MFC ≥32MIC). glabrata ≥2 μg/ml. By this more stringent method we found substantial those previously reported spp.

参考文章(19)
A. L. Barry, M. A. Pfaller, S. D. Brown, A. Espinel-Ingroff, M. A. Ghannoum, C. Knapp, R. P. Rennie, J. H. Rex, M. G. Rinaldi, Quality Control Limits for Broth Microdilution Susceptibility Tests of Ten Antifungal Agents Journal of Clinical Microbiology. ,vol. 38, pp. 3457- 3459 ,(2000) , 10.1128/JCM.38.9.3457-3459.2000
T J Walsh, G P Melcher, M G Rinaldi, J Lecciones, D A McGough, P Kelly, J Lee, D Callender, M Rubin, P A Pizzo, Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. Journal of Clinical Microbiology. ,vol. 28, pp. 1616- 1622 ,(1990) , 10.1128/JCM.28.7.1616-1622.1990
Branch T. Fields, Joseph H. Bates, Robert S. Abernathy, Amphotericin B Serum Concentrations During Therapy 1 Applied Microbiology. ,vol. 19, pp. 955- 959 ,(1970) , 10.1128/AM.19.6.955-959.1970
J.R. Greig, A.L. Brown, Bloodstream infections due to Candida species. Journal of Hospital Infection. ,vol. 56, pp. 247- 247 ,(2004) , 10.1016/J.JHIN.2003.12.008
MA Pfaller, RN Jones, GV Doern, HS Sader, SA Messer, A Houston, S Coffman, RJ Hollis, SENTRY Participant Group†, None, Bloodstream Infections Due to Candida Species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998 Antimicrobial Agents and Chemotherapy. ,vol. 44, pp. 747- 751 ,(2000) , 10.1128/AAC.44.3.747-751.2000
M. Hong Nguyen, Cornelius J. Clancy, Victor L. Yu, Yue C. Yu, Arthur J. Morris, David R. Snydman, Deanna A. Sutton, Michael G. Rinaldi, Do In Vitro Susceptibility Data Predict the Microbiologic Response to Amphotericin B? Results of a Prospective Study of Patients with Candida Fungemia The Journal of Infectious Diseases. ,vol. 177, pp. 425- 430 ,(1998) , 10.1086/514193
Guillermo Quindós, Alfonso Javier Carrillo-Muñoz, María Pilar Arévalo, Javier Salgado, Rocío Alonso-Vargas, José Manuel Rodrigo, María Teresa Ruesga, Anastasio Valverde, Javier Pemán, Emilia Cantón, Estrella Martín-Mazuelos, José Pontón, In vitro susceptibility of Candida dubliniensis to current and new antifungal agents Chemotherapy. ,vol. 46, pp. 395- 401 ,(2000) , 10.1159/000007320
Elizabeth M. Johnson, Joshua O. Ojwang, Adrien Szekely, Thomas L. Wallace, David W. Warnock, Comparison of In Vitro Antifungal Activities of Free and Liposome-Encapsulated Nystatin with Those of Four Amphotericin B Formulations Antimicrobial Agents and Chemotherapy. ,vol. 42, pp. 1412- 1416 ,(1998) , 10.1128/AAC.42.6.1412
Michael E. Klepser, Erika J. Ernst, Russell E. Lewis, Michael E. Ernst, Michael A. Pfaller, Influence of Test Conditions on Antifungal Time-Kill Curve Results: Proposal for Standardized Methods Antimicrobial Agents and Chemotherapy. ,vol. 42, pp. 1207- 1212 ,(1998) , 10.1128/AAC.42.5.1207